Nanoparticle (NP)-based delivery vehicles /
Gene therapy as a potential method for treatment of genetic disorders and other malignancies as well as treatment of many cancers has attracted a great amount of attention in recent years. Current research focuses on stable and smart drug/gene delivery systems, including controlled release. Smart na...
Clasificación: | Libro Electrónico |
---|---|
Autores principales: | , , , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
San Rafael [California] (40 Oak Drive, San Rafael, CA, 94903, USA) :
Morgan & Claypool Publishers,
[2019]
|
Colección: | IOP (Series). Release 5.
IOP concise physics. |
Temas: | |
Acceso en línea: | Texto completo |
MARC
LEADER | 00000nam a2200000 4500 | ||
---|---|---|---|
001 | IOP_9781643274522 | ||
003 | IOP | ||
005 | 20190408220440.0 | ||
006 | m eo d | ||
007 | cr cn |||m|||a | ||
008 | 190406s2019 caua ob 000 0 eng d | ||
020 | |a 9781643274522 |q ebook | ||
020 | |a 9781643274492 |q mobi | ||
020 | |z 9781643274492 |q print | ||
024 | 7 | |a 10.1088/2053-2571/ab01f6 |2 doi | |
035 | |a (CaBNVSL)thg00978699 | ||
035 | |a (OCoLC)1091997448 | ||
040 | |a CaBNVSL |b eng |e rda |c CaBNVSL |d CaBNVSL | ||
050 | 4 | |a RS201.N35 |b R336 2019eb | |
060 | 4 | |a WB 340 |b R116n 2019eb | |
072 | 7 | |a PHF |2 bicssc | |
072 | 7 | |a TEC021000 |2 bisacsh | |
082 | 0 | 4 | |a 615/.6 |2 23 |
100 | 1 | |a Rabiee, Navid, |e author. | |
245 | 1 | 0 | |a Nanoparticle (NP)-based delivery vehicles / |c Navid Rabiee, Mahsa Kiani, Mojtaba Bagherzadeh, Mohammad Rabiee, Sepideh Ahmadi. |
264 | 1 | |a San Rafael [California] (40 Oak Drive, San Rafael, CA, 94903, USA) : |b Morgan & Claypool Publishers, |c [2019] | |
264 | 2 | |a Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) : |b IOP Publishing, |c [2019] | |
300 | |a 1 online resource (various pagings) : |b illustrations (chiefly color). | ||
336 | |a text |2 rdacontent | ||
337 | |a electronic |2 isbdmedia | ||
338 | |a online resource |2 rdacarrier | ||
490 | 1 | |a [IOP release 5] | |
490 | 1 | |a IOP concise physics, |x 2053-2571 | |
500 | |a "Version: 20190301"--Title page verso. | ||
500 | |a "A Morgan & Claypool publication as part of IOP Concise Physics"--Title page verso. | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | |a 1. An introduction to drug/gene delivery systems -- 2. Smart nanostructures -- 2.1. Controlled gene delivery systems : the concept -- 3. Aptamer-based nanostructures -- 3.1. Aptamer-conjugated nanoparticles -- 4. Protein-based nanostructures I -- 4.1. Gelatin -- 5. Protein-based nanostructures II -- 5.1. Elastin -- 6. Protein-based nanostructures III -- 6.1. Silk synthesis approaches -- 6.2. Silk-based nanocarriers -- 7. Smart drug/gene delivery systems : toward the future. | |
520 | 3 | |a Gene therapy as a potential method for treatment of genetic disorders and other malignancies as well as treatment of many cancers has attracted a great amount of attention in recent years. Current research focuses on stable and smart drug/gene delivery systems, including controlled release. Smart nanostructures have been considered as a promising approach when applied to drug and gene delivery systems, and could solve the problems related to the inefficient transfer of medication to the affected cells. | |
521 | |a General/trade. | ||
530 | |a Also available in print. | ||
538 | |a Mode of access: World Wide Web. | ||
538 | |a System requirements: Adobe Acrobat Reader, EPUB reader, or Kindle reader. | ||
545 | |a Navid Rabiee graduated with an MSc degree in inorganic chemistry from Shahid Beheshti University, Tehran, Iran, in 2018. He also worked on Drug Delivery Systems based on biocompatible and biodegradable polymers associated with different types of the sensitizers, especially porphyrins, under the supervision of Professor Mohammad Rabiee at Amirkabir University of Technology, Tehran, Iran. In 2017, he joined ANNRG to collaborate with Professor Mahdi Karimi's Research lab in the Iran University of Medical Science, in association with Professor Michael R Hamblin from Harvard Medical University. Mahsa Kiani graduated with an MSc degree in inorganic chemistry from Isfahan University of Technology, Isfahan, Iran, in 2015. In 2019, she joined ANNRG to collaborate with Professor Mahdi Karimi's Research lab in Iran University of Medical Science, Tehran, Iran working on smart microcarriers/nanocarriers applied in therapeutic agent delivery systems employed for diagnosis and therapy of various diseases and disorders. Currently, she is a PhD candidate at Sharif University of Technology under the supervision of Professor Mojtaba Bagherzadeh and working on smart drug/gene delivery systems. Mohammad Rabiee, PhD, is an associated professor of Biomedical Engineering Department of Amirkabir University of Technology, Tehran, Iran. His current research interests include smart drug delivery systems, tissue engineering and biological sensors. He has published over 100 ISI papers and also over 70 international conference papers. In addition, he has been teaching and conducting research for 26 years at Amirkabir University of Technology, Tehran, Iran. Mojtaba Bagherzadeh, PhD, is a professor at the Department of Chemistry of Sharif University of Technology, Tehran, Iran. His current research interests include inorganic chemistry, inorganic catalysis and bio-inorganic chemistry. He has published over 100 ISI papers, with the H-Index of 29. Spideh Ahmadi received her BSc degree in biology from Lorestan University in 2011. In 2014, she received her MSc in Molecular Genetic from Zabol University, Zabol, Iran. During her MSc research, she worked on specific detection of Klebsiella pneumoniae by gold nanoparticles probe. Currently, she is working at Shahid Beheshti University of Medical Sciences as a PhD candidate in the field of Molecular Medicine. In 2018, she joined the Advanced Technologies Research Group to collaborate with Navid Rabiee and Professor Mohammad Rabiee, working on smart nanostructures applied in therapeutic agent delivery systems employed for the diagnosis and therapy of various diseases. | ||
588 | 0 | |a Title from PDF title page (viewed on April 1, 2019). | |
650 | 0 | |a Nanoparticles. | |
650 | 0 | |a Drug delivery systems. | |
650 | 0 | |a Gene therapy. | |
650 | 1 | 2 | |a Nanostructures. |
650 | 1 | 2 | |a Drug Delivery Systems. |
650 | 1 | 2 | |a Genetic Therapy |x methods. |
650 | 2 | 2 | |a Nanotechnology |x methods. |
650 | 7 | |a Materials / States of matter. |2 bicssc | |
650 | 7 | |a TECHNOLOGY & ENGINEERING / Materials Science / General. |2 bisacsh | |
700 | 1 | |a Kiani, Mahsa, |e author. | |
700 | 1 | |a Bagherzadeh, Mojtaba, |e author. | |
700 | 1 | |a Rabiee, Mohammad, |e author. | |
700 | 1 | |a Ahmadi, Sepideh, |e author. | |
710 | 2 | |a Morgan & Claypool Publishers, |e publisher. | |
710 | 2 | |a Institute of Physics (Great Britain), |e publisher. | |
776 | 0 | 8 | |i Print version: |z 9781643274492 |
830 | 0 | |a IOP (Series). |p Release 5. | |
830 | 0 | |a IOP concise physics. | |
856 | 4 | 0 | |u https://iopscience.uam.elogim.com/book/978-1-64327-452-2 |z Texto completo |